Letter by Garcia-Moll Regarding Article, â•œGlycemic Control Status After Percutaneous Coronary Intervention and Long-Term C
![IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients? IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?](https://pub.mdpi-res.com/ijms/ijms-23-14598/article_deploy/html/images/ijms-23-14598-g001.png?1669349494)
IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
![Frontiers | Undiagnosed Impaired Glucose Tolerance and Type-2 Diabetes in Acute Myocardial Infarction Patients: Fequency, Characteristics and Long-Term Mortality Frontiers | Undiagnosed Impaired Glucose Tolerance and Type-2 Diabetes in Acute Myocardial Infarction Patients: Fequency, Characteristics and Long-Term Mortality](https://www.frontiersin.org/files/Articles/869395/fcvm-09-869395-HTML/image_m/fcvm-09-869395-g001.jpg)
Frontiers | Undiagnosed Impaired Glucose Tolerance and Type-2 Diabetes in Acute Myocardial Infarction Patients: Fequency, Characteristics and Long-Term Mortality
![Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-021-01004-2/MediaObjects/13300_2021_1004_Fig8_HTML.png)
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink
Abhishek Sharma, MD *Maimonides Medical Center 1016 50th Street, Apt. 2C Brooklyn, New York 11219 E-mail: abhisheksharma4mamc@g
![Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile](https://i1.rgstatic.net/ii/profile.image/272738812166168-1442037408862_Q512/Kerstin-Elvin.jpg)
Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile
![Diagnostics | Free Full-Text | Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients Diagnostics | Free Full-Text | Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients](https://www.mdpi.com/diagnostics/diagnostics-11-02267/article_deploy/html/images/diagnostics-11-02267-g001.png)
Diagnostics | Free Full-Text | Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients
![Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes](https://www.thelancet.com/cms/attachment/70b98ada-bbc5-422e-b780-fada19a63a33/gr1_lrg.jpg)
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes
![JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus](https://www.mdpi.com/jcm/jcm-11-06530/article_deploy/html/images/jcm-11-06530-g001.png)
JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus
![Frontiers | Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review Frontiers | Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review](https://www.frontiersin.org/files/Articles/836365/fendo-13-836365-HTML-r1/image_m/fendo-13-836365-g002.jpg)
Frontiers | Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
![Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles | Circulation Research Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles | Circulation Research](https://www.ahajournals.org/cms/asset/8b3a04d8-ac8d-4abe-b728-85fd5c07e865/circresaha.120.317178.fig09.jpg)
Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles | Circulation Research
![Toxics | Free Full-Text | Perinatal Lead Exposure Promotes Sex-Specific Epigenetic Programming of Disease-Relevant Pathways in Mouse Heart Toxics | Free Full-Text | Perinatal Lead Exposure Promotes Sex-Specific Epigenetic Programming of Disease-Relevant Pathways in Mouse Heart](https://www.mdpi.com/toxics/toxics-11-00085/article_deploy/html/images/toxics-11-00085-g001.png)
Toxics | Free Full-Text | Perinatal Lead Exposure Promotes Sex-Specific Epigenetic Programming of Disease-Relevant Pathways in Mouse Heart
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study | PLOS Medicine
![Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1059_719514_1/Slide1.jpg)
Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD
![Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/de36fdc5-e9e5-49c1-aac3-57dc8363a91c/jah37324-fig-0001.png)
Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association
![JCDD | Free Full-Text | Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients JCDD | Free Full-Text | Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients](https://pub.mdpi-res.com/jcdd/jcdd-09-00006/article_deploy/html/images/jcdd-09-00006-g001-550.jpg?1640675772)